November 17, 2021
Life Sciences
  • The Biden administration plans to pay more than $5 billion for a stockpile of Pfizer’s new COVID-19 pill, enough for about 10 million courses of treatment to be delivered in the next 10 months. Senior federal health officials are counting on the five-day antiviral pill regimen, called Paxlovid, to help change the trajectory of the pandemic by reducing severe illness and deaths. The drug reduced the risk of hospitalization and death when given promptly to trial groups of high-risk unvaccinated people who developed symptoms of the disease. (Articles here, here, and here)